Table 3.

Tumor response at 12 weeks and overall best observed response per RECIST 1.1 criteria

	At 12 weeks N=57	Overall best response N=57
Complete response, n (%)	2 (3.5)	11 (19.3)
Partial response, n (%)	18 (31.6)	23 (40.4)
Objective response rate, %	35.1	59.6
Stable disease, n (%)	29 (50.9)	17 (29.8)
Progressive disease, n (%)	5 (8.8)	3 (5.3)
Confirmed progressive disease per iRECIST criteria	4 (7.0)	2 (3.5)
Pseudoprogression per iRECIST criteria	1 (1.8)	1 (1.8)
Non-evaluable, n (%)	3 (5.3)	3 (5.3)
Disease control rate per RECIST1.1/iRECIST, %	86.0/87.7	89.5/91.2

RECIST, Response Evaluation Criteria in Solid Tumors.